China Braces for Summer COVID Surge amid NB.1.8.1 Spread
In May, the Chinese Centre for Disease Control and Prevention identified NB.1.8.1 as the principal agent behind the sharp rise in cases nationwide, mirroring similar trends across Asian neighbours. Evidence from CDC screening in the United States detected NB.1.8.1 infections among travellers from Asia between late April and mid‑May, reinforcing concerns over its transmissibility. Preliminary Chinese research indicates the variant may bind more effectively to human cells than predecessors, potentially accelerating its spread.
Hospital insiders in China refer to an uptick in 'white lung' patterns—dense opacifications on chest scans—and sudden deaths among previously healthy middle‑aged adults, although experts emphasise the term remains colloquial and lacks precise medical definition. At the same time, nothing yet suggests the emergence of a new pathogen. Health agencies, including the WHO, note the wave aligns with rising circulation of known respiratory agents—COVID‑19, influenza, RSV and mycoplasma—without evidence of an unusual strain.
ADVERTISEMENT
Hospitals in Beijing and Liaoning report increased admission volumes, with clinics in cities like Dalian and Chongqing grappling with larger-than-normal respiratory caseloads. Despite this, national health statements have stressed that surveillance shows no new pathogens, attributing the climb to seasonal factors and immunological gaps following post‑lockdown easing.
Regional governments have reinstated basic safeguards—including mask recommendations on mass transit and in healthcare settings—in response to the epidemiological models forecasting July peaks. Authorities in Taiwan have also begun stockpiling vaccines and antivirals in anticipation of increased demand.
Global health bodies are closely monitoring: CDC representatives in the U.S. maintain active communication with counterparts in China, Hong Kong and Taiwan regarding variant spread. Several cases of NB.1.8.1 have been recorded at U.S. ports of entry, though limited sequencing has so far prevented it from showing up prominently in national variant dashboards.
In vaccine policy circles, U.S. regulators are debating updates for the autumn season, with mRNA manufacturers presenting candidate boosters targeting JN.1 lineages—such as LP.8.1—that could also offer immunity against NB.1.8.1.
Metapneumovirus, an endemic respiratory pathogen, was also notably active during winter 2024–2025 in China, accounting for over 6 per cent of positive respiratory illness tests and hospitalisations. Health officials affirmed this activity was consistent with typical seasonal patterns.
Medical experts stress that while chest imaging showing 'white-out' lung appearance can be alarming, it is not indicative of a novel syndrome; it occurs with severe pneumonia from various known agents. Treatment protocols remain standard, including antibiotics for bacterial pneumonia and antivirals when appropriate.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
13 hours ago
- Zawya
The World Health Organization (WHO) Director-General and Regional Director for Africa begin official visit to Ghana ahead of Africa Health Sovereignty Summit
The Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus, and the WHO Regional Director for Africa, Dr Mohammed Yakubu Janabi, have commenced an official visit to Ghana from 4–6 August 2025. Their visit comes ahead of the Africa Health Sovereignty Summit: The Accra Compact, scheduled for 5 August in Accra, and signals a renewed commitment to advancing regional cooperation on sustainable financing for health and systems resilience. The Summit takes place at a time of mounting global health challenges and constrained financing, with countries across Africa striving to build stronger, more resilient health systems. Ghana's recent progress in universal health coverage, local vaccine manufacturing, and emergency preparedness demonstrates the country's growing leadership in shaping sustainable and equitable health outcomes. During their stay, Dr Tedros and Dr Janabi will hold high-level meetings with national authorities including H.E. John Dramani Mahama, President of the Republic of Ghana and key stakeholders to reaffirm WHO's support for Ghana's health priorities. The summit will convene African heads of state, health ministers, and global partners to align national, regional, and global agendas around the principles of self-reliance, innovation, and coordinated action. The delegation includes senior officials from WHO headquarters in Geneva, the WHO Regional Office for Africa, and the WHO Ghana Country Office. The visit is expected to reaffirm WHO's technical partnership with Ghana while spotlighting the country's leadership in advancing inclusive and sustainable health development across the continent. Distributed by APO Group on behalf of World Health Organization (WHO), Ghana.
Gulf Today
a day ago
- Gulf Today
The most and least infectious diseases on the planet
Dan Baumgardt, The Independent When the COVID pandemic hit, many people turned to the eerily prescient film Contagion (2011) for answers — or at least for catharsis. Suddenly, its hypothetical plot felt all too real. Applauded for its scientific accuracy, the film offered more than suspense — it offered lessons. One scene in particular stands out. Kate Winslet's character delivers a concise lesson on the infectious power of various pathogens — explaining how they can be spread from our hands to the many objects we encounter each day — "door knobs, water fountains, elevator buttons and each other". These everyday objects, known as fomites, can become silent vehicles for infection. She also considered how each infection is given a value called R0 (or R-nought) based on how many other people are likely to become infected from another. So, for an R0 of two, each infected patient will spread the disease to two others. Who will collectively then give it to four more. And so a breakout unfolds. The R0 measure indicates how an infection will spread in a population. If it's greater than one, the outcome is disease spread. An R0 of one means the level of people being infected will remain stable, and if it's less than one, the disease will often die out with time. Circulating infections spread through a variety of routes and differ widely in how contagious they are. Some are transmitted via droplets or aerosols — such as those released through coughing or sneezing — while others spread through blood, insects (like ticks and mosquitoes), or contaminated food and water. But if we step back to think about how we can protect ourselves from developing an infectious disease, one important lesson is in understanding how they spread. And as we'll see, it's also a lesson in protecting others, not just ourselves. Here is a rundown of some of the most and least infectious diseases on the planet. In first place for the most contagious is measles. Measles has made a resurgence globally in recent years, including in high-income countries like the UK and the US. While several factors contribute to this trend, the primary cause is a decline in childhood vaccination rates. This drop has been driven by disruptions such as the COVID pandemic and global conflict, as well as the spread of misinformation about vaccine safety. The R0 number for measles is between 12 and 18. If you do the maths, two cycles of transmission from that first infected person could lead to 342 people catching the illness. That's a staggering number from just one patient — but luckily, the protective power of vaccination helps reduce the actual spread by lowering the number of people susceptible to infection. Measles is extraordinarily virulent, spreading through tiny airborne particles released during coughing or sneezing. It doesn't even require direct contact. It's so infectious that an unvaccinated person can catch the virus just by entering a room where an infected person was present two hours earlier. People can also be infectious and spread the virus before they develop symptoms or have any reason to isolate. Other infectious diseases with high R0 values include pertussis, or whooping cough (12 to 17), chickenpox (ten to 12), and COVID, which varies by subtype but generally falls between eight and 12. While many patients recover fully from these conditions, they can still lead to serious complications, including pneumonia, seizures, meningitis, blindness, and, in some cases, death. Low spread, high stakesAt the other end of the spectrum, a lower infectivity rate doesn't mean a disease is any less dangerous. Take tuberculosis (TB), for example, which has an R0 ranging from less than one, up to four. This range varies depending on local factors like living conditions and the quality of available healthcare. Caused by the bacterium Mycobacterium tuberculosis, TB is also airborne but spreads more slowly, usually requiring prolonged close contact with someone with the active disease. Outbreaks tend to occur among people who share living spaces — such as families, households, and in shelters or prisons. The real danger with TB lies in how difficult it is to treat. Once established, it requires a combination of four antibiotics taken over a minimum of six months. Standard antibiotics like penicillin are ineffective, and the infection can spread beyond the lungs to other parts of the body, including the brain, bones, liver and joints. What's more, cases of drug-resistant TB are on the rise, where the bacteria no longer respond to one or more of the antibiotics used in treatment. Other diseases with lower infectivity include Ebola, which is highly fatal but spreads through close physical contact with bodily fluids. Its R0 ranges from 1.5 to 2.5. Diseases with the lowest R0 values — below one — include Middle East respiratory syndrome (Mers), bird flu and leprosy. While these infections are less contagious, their severity and potential complications should not be underestimated. The threat posed by any infectious disease depends not only on how it affects the body, but also on how easily it spreads. Preventative measures like immunisation play a vital role - not just in protecting people, but also in limiting transmission to those who cannot receive some vaccinations - such as infants, pregnant women and people with severe allergies or weakened immune systems. These individuals are also more vulnerable to infection in general. This is where herd immunity becomes essential. By achieving widespread immunity within the population, we help protect people who are most susceptible.
Zawya
a day ago
- Zawya
Africa speaks out: World Health Organization (WHO) consultations bring urgency and hope to health worker migration crisis
When health experts across the WHO African region, logged into the virtual WHO consultation on 30 July 2025, they knew the stakes were high. Across the continent, hospitals are losing nurses to overseas recruiters, clinics are short-staffed, and young medical graduates face the dilemma of staying to serve or leaving in search of better pay. This isn't just policy—it's personal. From Praia to Port Louis, governments and health professionals are sounding the alarm: Africa is losing too many of its trained health workers to international migration. And while global demand for medical personnel has soared in the wake of the COVID-19 pandemic, African countries are bearing the cost. In response, the World Health Organization's Regional Office for Africa has launched a series of consultations with its 47 Member States to revisit the WHO Global Code of Practice on the International Recruitment of Health Personnel. First adopted in 2010, the Code was designed to ensure fairness in how countries recruit health workers across borders. But fifteen years on, it needs a refresh—and Africa is determined to shape it. Dr Adelheid Werimo Onyango, Director of Health Systems and Services at the WHO Regional Office for Africa underscored said: 'These consultations represent a critical opportunity for African countries to ensure the Code truly reflects our regional realities and priorities,' noting that 'ultimately, our goal is to ensure that the Code remains not just a document on a shelf, but a living, actionable instrument that guides international recruitment in ways that strengthen Africa's health systems.' The consultation brought together representatives from 30 countries. Their goal: to make sure Africa's voice is heard loud and clear when the final report goes to the 156th WHO Executive Board. The consultation was guided by three key objectives: (1) to review the findings and recommendations of the Expert Advisory Group on the Code's current relevance and effectiveness; (2) to provide concrete recommendations for strengthening the Code's effectiveness in addressing both current and emerging health workforce challenges in Africa and globally; and (3) to build consensus on regional priorities and peculiarities that must be reflected in the revised Code. For many participants, the discussion hit close to home. Several spoke of empty clinics in rural districts, of experienced doctors, laboratory experts and nurses departing overnight for contracts in Europe or the Gulf, of overstretched systems trying to do more with less. 'Through your recommendations and suggestions, you are laying a solid foundation for a stronger and more equitable health workforce across Africa,' said Dr James Avoka Asamani, Health Workforce Team Lead at the WHO Regional Office for Africa stressing the importance of providing feedback. Many referenced the Africa Health Workforce Investment Charter, which recognizes that effective migration management is vital to addressing the region's looming shortfall of 6.1 million health workers by 2030. Countries stressed that the revised Code must go beyond principles and offer enforceable guidance, especially in the face of aggressive international recruitment. The heart of the consultations, however, wasn't just policy reform—it was about people. It was about an African midwife who has trained hundreds of birth attendants, only to watch them leave for better-paying jobs abroad. It was about a young doctor torn between duty and ambition. And it was about families across Africa who deserve quality care—delivered by professionals who stay. In the coming weeks, WHO will continue gathering input from across the region. But one thing is clear—the African region is not sitting this one out. It's leading the conversation. Because when it comes to health worker migration, the region knows the human cost all too well—and is ready to chart a new path forward. Distributed by APO Group on behalf of WHO Regional Office for Africa.
